HEAL has written a letter to EU heads of states and governments ahead of the meeting, calling on them to Invest in prevention, protect health: Increase EU funding for climate resilience and pollution prevention.
On 19 November 2026, the European Chemicals Agency (ECHA) confirmed that the Committee for Socio-Economic Analysis (SEAC) adopted its opinion on the universal PFAS restriction and that SEAC supports the proposed restriction of PFAS as a group as the most appropriate risk management option.
The Committee found that the existing EU regulatory measures are not sufficient to control PFAS emissions and risks and therefore support further EU-wide action. According to the draft summary records of the Committee’s discussions, SEAC considers the proposed restriction, including appropriate derogations, implementable, manageable, enforceable, and monitorable.
Considering the growing body of scientific evidence that links PFAS exposure to an increased risk of severe health impacts and the staggering cost of inaction, HEAL calls on the European Commission to swiftly deliver a draft proposal for a broad restriction of PFAS. HEAL expects that the European Commission bases its draft proposal on the recommendations of the two expert committees, RAC and SEAC, and only considers time-limited exemptions for specific PFAS uses where no alternatives are available yet.
SEAC’s final opinion will be published by ECHA in the next weeks. It complements the opinion of the Risk Assessment Committee (RAC) on the risks of PFAS to humans and the environment, which was adopted in March 2026. As a next step, the European Commission has to propose a draft restriction of PFAS, based on the opinions of the two expert Committees, and discuss it with EU member states in the REACH Committee.

